Editorial Expression of Concern: HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats.

Saved in:
Bibliographic Details
Title: Editorial Expression of Concern: HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats.
Authors: Tao HQ; Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China., Meng Q; Department of Ophthalmology, First Affiliated Hospital of Harbin Medical University, Harbin, China., Li MH; Department of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.; Research and Development of Natural Products Key Laboratory, Harbin Medical University, Daqing, China., Yu H; Department of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.; Research and Development of Natural Products Key Laboratory, Harbin Medical University, Daqing, China., Liu MF; Department of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.; Research and Development of Natural Products Key Laboratory, Harbin Medical University, Daqing, China., Du D; Department of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.; Research and Development of Natural Products Key Laboratory, Harbin Medical University, Daqing, China., Sun SL; Department of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.; Research and Development of Natural Products Key Laboratory, Harbin Medical University, Daqing, China., Yang HC; Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China., Wang YM; Department of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.; Research and Development of Natural Products Key Laboratory, Harbin Medical University, Daqing, China., Ye W; Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China., Yang LZ; Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China., Zhu DL; Department of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China.; Research and Development of Natural Products Key Laboratory, Harbin Medical University, Daqing, China., Jiang CL; Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China. jcl6688@163.com., Peng HS; Department of Pharmaceutics, Daqing Branch, Harbin Medical University, Daqing, China. fisher1688@163.com.
Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2025 Oct; Vol. 398 (10), pp. 14537.
Publication Type: Expression of Concern
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1432-1912
DOI:10.1007/s00210-025-04437-9